As Chief Operating Officer of Rakuten Medical, Abhijit Bhatia oversees a broad range of corporate functions, including finance and accounting, business development, corporate communications and investor relations, as well as artificial intelligence and information technology.

With more than two decades of experience across the biopharmaceutical industry, Abhijit plays a key role in shaping Rakuten Medical’s corporate strategy and translating it into execution. Since joining the company, he has led and supported a number of strategic transactions and partnerships with global pharmaceutical companies and academic institutions. These initiatives include a significant long-term supply agreement for a critical material, the acquisition of the photoactivatable dye IR700, and the acquisition of Medlight, where he established the strategic direction to secure reliable device supply for clinical development and commercialization.

Abhijit has also played an instrumental role in raising more than $700 million in capital to support Rakuten Medical’s growth and development. He has helped establish and deepen the company’s relationships across the U.S. capital markets, building trusted relationships with leading institutional investors, investment banks, and the broader Wall Street healthcare community. These efforts have strengthened Rakuten Medical’s engagement with the investment community and supported its long-term financing and corporate development strategy.

Prior to joining Rakuten Medical, Abhijit held research, development, and management roles at Celgene, Abraxis Biosciences, Amgen, the Saban Research Institute at Children’s Hospital Los Angeles, and Cleveland Clinic Foundation.

Abhijit earned an M.S. in Chemical Engineering from Cleveland State University in collaboration with Cleveland Clinic Foundation and an MBA from the UCLA Anderson School of Management.